About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
S
SGLT Inhibitors in Heart Failure
By
Sara D Brouse
607 views
October 1, 2024
0 Comments
Login to view comments.
Click here to Login
Featured Video
04:47
Novartis Cardiology
Examining MOA, Safety, and Efficacy Data for a Non-Statin Lipid-Lowe…
Featured Video
10:56
Novartis Cardiology
Expert Insights on Pivotal Phase 3 and Long-term Trial Data in Prima…
Feat.
D. G. Karalis,
M. Myerson
Related Content
AUTOPLAY
ON
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments
Primer on Diabetes Management
Feat.
S. Inzucchi
11:37
ACC 2022 Conference Coverage
ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…
Feat.
P. Heidenreich
11:25
ACC 2023 Conference Coverage
ACC 2023: SGLT2i Use - Dos and Don'ts
Feat.
A. Armbruster
27:14
MUSC Cardiology
Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Tr…
Feat.
R. Mentz
18:43
ASPC 2019 Congress on CVD Prevention
Diabetes Treatment Guidelines Finally Have Entered the 21st Century …
Feat.
R. DeFronzo
55:12
University of Louisville
Current Trends in Obesity Pharmacotherapy: Is the Wait (Weight) Over?
Feat.
S. S. Krishnasamy
26:01
Cardiology Fiesta 2017
Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…
Feat.
R. DeFronzo
27:24
Cardiometabolic Health Congress (CMHC)
SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes
Feat.
L. Sloan
17:44
Rita Jermyn
SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease
09:52
AHA 2022 Conference Coverage
AHA 2022: Torsemide Comparison With Furosemide for Management of Hea…
Feat.
R. Mentz
13:07
Michelle Kittleson
2021 ADA Highlights: Heart Failure With Reduced Ejection Fraction - …
61:49
Obafemi Awolowo University
Management of Heart Failure
Feat.
O. A. Akinyele
03:03
Boehringer Ingelheim and Lilly Cardiology
The Shift to Rapid Sequencing to Improve Patient Outcomes in HFrEF
Feat.
K. Watson
35:16
Scripps Health
HFpEF or Amyloidosis? The Right Therapies for Right Patients
Feat.
M. Kittleson
22:42
Heart in Diabetes (HiD)
Functional Hypothalamic Amenorrhea: Consequences Beyond the Menstrua…
Feat.
C. Shufelt
18:39
Heart in Diabetes (HiD)
Cardiovascular Disease in the Very Old
Feat.
C. Ballantyne
28:48
MUSC Cardiology
Weight Loss as Treatment for HFpEF: An Update on Drugs and Procedures
Feat.
S. Litwin
28:46
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Heart Failure Case Presentations
Feat.
B. Greenberg,
G. Fonarow,
N. Wettersten,
M. Rosa Costanzo
09:00
Cecilia Bahit
The Best of AHA23 for the Primary Care Doctor
19:30
ACC 2022 Conference Coverage
Hot Topics in Heart Failure ACC.22
Feat.
N. Ibrahim